(Q39568646)
Statements
Amplification of the driving oncogene, KRAS or BRAF, underpins acquired resistance to MEK1/2 inhibitors in colorectal cancer cells (English)
Annette S Little
Kathryn Balmanno
Matthew J Sale
Jonathan R Dry
Mark Hampson
Paul A W Edwards
Paul D Smith
1 reference
1 reference